Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp.

Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases

(2020) Ruslan Tsivkovski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of sulbactam/durlobactam against clinical isolates of Acinetobacter baumannii collected in China

(2020) Qiwen Yang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

6-Arylmethylidene Penicillin-Based Sulfone Inhibitors for Repurposing Antibiotic Efficiency in Priority Pathogens

(2020) Diana Rodríguez et al.   JOURNAL OF MEDICINAL CHEMISTRY

In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii

(2020) Harald Seifert et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii

(2020) Kirk Nelson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

β-Lactamases and β-Lactamase Inhibitors in the 21st Century

(2019) Catherine L. Tooke et al.   JOURNAL OF MOLECULAR BIOLOGY

Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii

(2019) Juan Carlos Vázquez-Ucha et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs

(2019) Concepción González-Bello et al.   JOURNAL OF MEDICINAL CHEMISTRY

In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015

(2018) James A. Karlowsky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Epidemiology and Mechanism of Sulbactam Resistance in Acinetobacter baumannii Isolates with Diverse Genetic Backgrounds in China

(2018) Yunxing Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme

(2018) James A Karlowsky et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains

(2018) Yunxing Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514

(2017) Adam B. Shapiro et al.   ACS Infectious Diseases

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

(2017) Thomas F. Durand-Réville et al.   Nature Microbiology

Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options

(2015) Gerald Murray et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections

(2014) J. Alexander Viehman et al.   DRUGS

New mutations in ADC-type β-lactamases from Acinetobacter spp. affect cefoxitin and ceftazidime hydrolysis

(2014) Astrid Pérez et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii

(2013) C. Rumbo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii

(2013) S. T. Housman et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-Spectrum AmpC Cephalosporinase in Acinetobacter baumannii: ADC-56 Confers Resistance to Cefepime

(2011) Guo-Bao Tian et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penicillin Sulfone Inhibitors of Class D  -Lactamases

(2010) S. M. Drawz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cefepime: a reappraisal in an era of increasing antimicrobial resistance

(2008) Andrea Endimiani et al.   Expert Review of Anti-Infective Therapy

Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program

(2008) R. E. Mendes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Strategic Design of an Effective β-Lactamase Inhibitor

(2008) Priyaranjan Pattanaik et al.   JOURNAL OF BIOLOGICAL CHEMISTRY